Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Complications

Progenitor and lymphoma cells in blood stem cell harvests: impact on survival following transplantation

Abstract

This study evaluated whether cytokine-induced blood stem cell mobilization also mobilized lymphoma cells and whether lymphoma cell mobilization affected outcome post autologous blood stem cell transplant. Blood stem cell collections from 26 non-Hodgkin's lymphoma (NHL) patients harvested during steady-state (non-mobilized) and from 35 NHL patients harvested after cytokine administration (mobilized) were studied. The harvests were cultured and molecularly evaluated for clonal markers of the primary lymphoma. All patients underwent high-dose chemotherapy and autologous transplantation. Graft products from mobilized patients were more likely to contain lymphoma than graft products from non-mobilized patients (37% vs 19%) but this difference was not significant (P = 0.16). In a multivariate analysis, lymphoma contamination was not associated with patient age, gender, tumor grade, prior radiotherapy, duration of prior chemotherapy, mononuclear cell count, or the number of aphereses performed to obtain the product. Heavily pre-treated patients were less likely to have lymphoma-contaminated harvests (P = 0.064). Lymphoma contamination was positively associated with the number of progenitor cells collected (P = 0.047). In multivariate analyses, the only significant independent predictor of lymphoma contamination was the number of mononuclear cells collected (P = 0.031). Lymphoma contamination of transplanted apheresis products had no apparent impact on event-free and overall survival. Bone Marrow Transplantation (2001) 28, 207–212.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Brugger W, Bross JK, Glatt M et al. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors Blood 1994 83: 636–640

    CAS  PubMed  Google Scholar 

  2. Lemoli RM, Fortuna A, Motta MR et al. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients; positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells Blood 1996 87: 1625–1634

    CAS  PubMed  Google Scholar 

  3. Kessinger A, Bierman PJ, Cowles MK et al. Mobilized versus non-mobilized peripheral stem cell transplantation after high dose therapy for low grade non-Hodgkin lymphoma: effect on failure-free survival Cancer Res Ther Control 1998 5: 113–119

    Google Scholar 

  4. Sharp JG, Armitage J, Crouse D et al. Are occult tumor cells present in peripheral stem cell harvests of candidates for autologous transplantation? In: Dicke KA, Spitzer G, Jagannath S, Evinger-Hodges MJ (eds) Autologous Bone Marrow Transplantation IV MD Anderson: Houston 1989 pp 693–696

    Google Scholar 

  5. Wu GQ, Sharp JG, Vose J et al. The detection of minimal lymphoma by molecular and combined culture-molecular methods Br J Haematol 1997 99: 873–881

    Article  CAS  PubMed  Google Scholar 

  6. National Cancer Institute . National Cancer Institute sponsored sutdy of classifications of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage Cancer 1982 49: 1112–1135

    Article  Google Scholar 

  7. Sharp JG, Kessinger A, Mann S et al. Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest J Clin Oncol 1996 14: 214–219

    Article  CAS  PubMed  Google Scholar 

  8. Joshi SS, Novak DJ, Messbarger L et al. Levels of detection of tumor cells in human bone marrow with or without prior culture Bone Marrow Transplant 1990 6: 179–183

    CAS  PubMed  Google Scholar 

  9. Sharp JG, Kessinger A, Armitage JO et al. Clinical significance of occult tumor cell contamination of hematopoietic harvests in non-Hodgkin's lymphoma and Hodgkin's disease In: Zander A, Barlogie B (eds) Autologous Bone Marrow Transplantation for Hodgkin's Disease, non-Hodgkin's Lymphoma and Multiple Myeloma Springer-Verlag: New York 1993 pp 123–132

    Google Scholar 

  10. Sharp JG, Bishop M, Chan WC et al. Detection of minimal residual disease in hematopoietic tissues In: Sackstein R, Janssen WE, Elfbein GJ (eds) Bone Marrow Transplantation: Foundations for the 21st Century The New York Academy of Sciences: New York 1995 pp 242–261

    Google Scholar 

  11. Kessinger A . Consensus conference on high-dose therapy with hematopoietic stem cell transplantation in diffuse large-cell lymphoma. Type of cells, optimal mobilization of stem cells-positive and negative selection Ann Oncol 1998 9: (Suppl. 1) 23–30

    Article  Google Scholar 

  12. Bensinger W, Appelbaum F, Rowley S et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells J Clin Oncol 1995 13: 2547–2555

    Article  CAS  PubMed  Google Scholar 

  13. Haas R, Möhle R, Frühauf S et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma Blood 1994 83: 3787–3794

    CAS  PubMed  Google Scholar 

  14. Anthony RS, McKelvie ND, Cunningham AJ et al. Flow cytometry using annexin V can detect early apoptosis in peripheral blood stem cell harvests from patients with leukemia and lymphoma Bone Marrow Transplant 1998 21: 441–446

    Article  CAS  PubMed  Google Scholar 

  15. Weekes CD, Kuszynski CA, Sharp JG . VLA-4 mediated adhesion to bone marrow stromal cells confers chemoresistance to adherent lymphoma cells Leuk Lymphoma 2001 40: 631–645

    Article  CAS  PubMed  Google Scholar 

  16. Weekes CD, Pirruccello SJ, Vose JM et al. Lymphoma cells associated with bone marrow stromal cells in culture exhibit altered growth and survival Leuk Lymphoma 1998 31: 151–165

    Article  CAS  PubMed  Google Scholar 

  17. Sharp JG, Joshi SS, Armitage JO et al. Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture technique Blood 1992 79: 1074–1080

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Sally Mann for technical support and Dr Grant Wu for assistance with molecular studies. We thank Martin Bast for patient follow-up, Dr Hakan Akbulut for his advice and analysis and Penni Davis who typed the manuscript. This research was supported in part by grants from the National Institutes of Health CA 61453, CA 61488 and State of Nebraska Department of Health LB 595 funds. Dr A Demirkazik was a recipient of NIH fellowship. This support is gratefully acknowledged.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Demirkazik, A., Kessinger, A., Armitage, J. et al. Progenitor and lymphoma cells in blood stem cell harvests: impact on survival following transplantation. Bone Marrow Transplant 28, 207–212 (2001). https://doi.org/10.1038/sj.bmt.1703124

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703124

Keywords

This article is cited by

Search

Quick links